Pharmacogenomics and the Fundamentals of Genotype-Guided Prescribing

Date:  Dec 15, 2022
1:00 pm - 2:00 pm ET
Location: Webinar


Interested in gaining a deeper understanding of pharmacogenomics? Join us for the final webinar of 2022 this Dec. 15 at 1 pm ET as Meagan Shields leads us through the background, clinical applications, resources, and current evidence being used in this field. 
Presenter: Meagan Sheilds

Pharmacogenomics (PGx) involves use of knowledge of a person’s genotype to various functional proteins (e.g. drug metabolizing enzymes, transporters, receptors, etc.) to predict pharmacokinetic and/or pharmacodynamic responses to medication. This information can be used with evidence-based resources, such as the Clinical Pharmacogenetics Consortium (CPIC) guidelines, to tailor medication therapy in order to avoid inefficacy and/or side-effects. A number of studies have demonstrated the impact of PGx on improving patient outcomes, however large-scale implementation within Canada has not yet occurred. Barriers to this include the limited knowledge healthcare providers have towards fundamentals and practical implementation of clinical pharmacogenomics. This session aims to improve this knowledge gap among pharmacists by introducing the background, clinical applications, resources, and current evidence supporting the use of pharmacogenomics in pharmacy practice. 

Learning Objectives:

  • Describe how genetics play a role in medication therapy response
  • Find pharmacogenomics prescribing guidelines with at least one internet-accessible resource
  • Identify at least 3 medications/drug classes with guidelines supporting genotype-guided prescribing 

Register here